Am. J. Respir. Crit. Care Med., Vol 152, No. 3, Sep 1995, 1041-1049.
BCG priming enhances endotoxin-induced acute lung injury independent of neutrophils
S Tasaka, A Ishizaka, T Urano, K Sayama, F Sakamaki, H Nakamura, T Terashima, Y Waki, K Soejima and Y Oyamada
Department of Medicine, School of Medicine, Keio University, Tokyo, Japan.
Bacillus Calmette Guerin (BCG) is known to increase susceptibility to
endotoxin in some animal species. We investigated the effect of BCG-
priming and the role of neutrophils in the priming process on the
pathogenesis of acute lung injury caused by intravenously administered
Escherichia coli endotoxin (LPS). Guinea pigs were divided into seven
groups: (1) control (n = 8), (2) BCG-alone (n = 6), (3) cyclophosphamide
(CPA)-alone (n = 6), (4) CPA+LPS (n = 6), (5) LPS- alone (n = 6), (6)
BCG+LPS (n = 6), and (7) BCG+CPA+LPS (n = 6). A BCG dose of 8 mg/kg was
injected subcutaneously 10 d before the study. CPA was administered
intraperitoneally to induce peripheral neutropenia. Animals were observed
for 4 h after intravenous administration of 0.2 mg/kg of LPS. The plasma
TNF level was measured 2 h after LPS challenge. Lung wet-to-dry weight
ratio, [125I] albumin leakage in lung tissue, differential cell count in
bronchoalveolar lavage (BAL) fluid, and histopathologic features were
examined immediately after death. Although the LPS-alone group showed PMN
accumulation in lung tissue, neither excess lung water nor increased
albumin leakage was induced by this dose of LPS. The BCG+LPS group showed
increased lung water, histopathologic edema, and increases in BAL fluid
cell counts and plasma TNF in comparison with the LPS-alone group. The
BCG+CPA+LPS group also showed enhanced lung injury comparable to that seen
in the BCG+LPS group. In both the CPA-alone and the CPA+LPS groups, no
parameter was increased as compared with those in the control
group.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:

|
 |

|
 |
 
M. Sawafuji, A. Ishizaka, M. Kohno, H. Koh, S. Tasaka, Y. Ishii, and K. Kobayashi
Role of Rho-kinase in reexpansion pulmonary edema in rabbits
Am J Physiol Lung Cell Mol Physiol,
December 1, 2005;
289(6):
L946 - L953.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Tasaka, H. Koh, W. Yamada, M. Shimizu, Y. Ogawa, N. Hasegawa, K. Yamaguchi, Y. Ishii, S. E. Richer, C. M. Doerschuk, et al.
Attenuation of Endotoxin-Induced Acute Lung Injury by the Rho-Associated Kinase Inhibitor, Y-27632
Am. J. Respir. Cell Mol. Biol.,
June 1, 2005;
32(6):
504 - 510.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Mokart, B. P. Guery, R. Bouabdallah, C. Martin, J.-L. Blache, C. Arnoulet, and J.-L. Mege
Deactivation of Alveolar Macrophages in Septic Neutropenic ARDS
Chest,
August 1, 2003;
124(2):
644 - 652.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Tasaka, A. Ishizaka, W. Yamada, M. Shimizu, H. Koh, N. Hasegawa, Y. Adachi, and K. Yamaguchi
Effect of CD14 Blockade on Endotoxin-Induced Acute Lung Injury in Mice
Am. J. Respir. Cell Mol. Biol.,
August 1, 2003;
29(2):
252 - 258.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. YAMADA, H. MIYAZAKI, T. KIKUCHI, J. FUJIMOTO, and I. KUDOH
Acid Instillation Enhances the Inflammatory Response to Subsequent Lipopolysaccharide Challenge in Rats
Am. J. Respir. Crit. Care Med.,
October 1, 2000;
162(4):
1366 - 1371.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ogata, T. Matsui, T. Kita, and A. Shigematsu
Carrageenan Primes Leukocytes To Enhance Lipopolysaccharide-Induced Tumor Necrosis Factor Alpha Production
Infect. Immun.,
July 1, 1999;
67(7):
3284 - 3289.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 American Thoracic Society
|
|
|